Somatico Pharmacal Private Limited, a active private limited company, was established on 20 August 1977 in Navi Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230MH1977PTC019812. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.60 M.
It upholds a compliant status. Employing 176 professional, Its leadership includes Samita Harish Chandrashekar Aiyer (Director), Dipali Amey Rao (Director). Past directors included Rohidas Rangnath Date, Geetha Srinivasan Balsara, Swadesh Kumar Kapur. It holds ₹1.50 Cr open charges and ₹3.35 Cr settled loans. Its latest AGM occurred on 23 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. C-469, Midc-Ttc Industrial Area, Pawane, Navi Mumbai, Maharashtra, 400705.
U24230MH1977PTC019812
019812
20 August 1977
₹2.00 Cr
₹1.60 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Somatico Pharmacal Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Samita Harish Chandrashekar Aiyer | Director | 01 Sep 1979 | Current |
| Dipali Amey Rao | Director | 09 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2022 | Past |
| Pramod Abcsdd | Alternate Director | 06 Aug 2018 | Past |
| Pramod Abcsdd | Managing Director | 18 Jan 2015 | Past |
| Pramod Abcsdd | Whole-Time Director | 12 Feb 2016 | Past |
| Pramod Abcsdd | Director | 16 Jan 2020 | Past |
| Pramod Abcsdd | Whole-Time Director | 12 Jul 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Somatico Pharmacal Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.55% increase. The company also saw a substantial improvement in profitability, with a 555.59% increase in profit. The company's net worth Soared by an impressive increase of 13.7%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Somatico Pharmacal had a public holding of 19.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹15,000,000.00
₹33,483,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Sep 2020 | Hdfc Bank Limited | ₹1.50 Cr | Open |
| 16 Feb 2019 | Hdfc Bank Limited | ₹3.00 M | Satisfied |
| 20 Mar 2018 | Others | ₹1.00 M | Satisfied |
| 18 Jul 2017 | Others | ₹0.80 M | Satisfied |
| 04 Jul 2017 | Others | ₹1.00 M | Satisfied |
Explore comprehensive loan charge details -
Somatico Pharmacal has a workforce of 176 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Somatico Pharmacal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Somatico Pharmacal's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Somatico Pharmacal Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records. was documented.
Progress on Somatico Pharmacal Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on A charge registered on 16 Feb 2019 via Charge ID 100244727 with Hdfc Bank Limited was fully satisfied on 07 Feb 2024. was documented.
A charge registered on 02 May 2016 via Charge ID 100042472 with Hdfc Bank Limited was fully satisfied on 03 Aug 2021. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.50 Cr with Charge ID 100364283 was registered on 02 Sep 2020. was documented.
The activity A charge registered on 20 Mar 2018 via Charge ID 100167546 with Others was fully satisfied on 11 Aug 2020. was completed.
The CIN of Somatico Pharmacal Private Limited is U24230MH1977PTC019812.
Somatico Pharmacal Private Limited is headquartered at Plot No. C-469, Midc-Ttc Industrial Area, Pawane, Navi Mumbai, Maharashtra, 400705.
Somatico Pharmacal Private Limited was incorporated on 20 August 1977.
The current directors of Somatico Pharmacal Private Limited are
The primary industry of Somatico Pharmacal Private Limited is Trade.
Somatico Pharmacal Private Limited is unlisted.
The authorized capital of Somatico Pharmacal Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.60 M.
The compliance status of Somatico Pharmacal Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX